Download PDF
Endoscopy 2007; 39(2): 118-123
DOI: 10.1055/s-2007-966125
Endoscopy essentials

© Georg Thieme Verlag KG Stuttgart · New York

Gastroesophageal reflux disease and Barrett’s esophagus

M.  Bittinger1 , H.  Messmann1
  • 1Department of Internal Medicine III, Klinikum Augsburg, Augsburg, Germany
Further Information

Publication History

Publication Date:
27 February 2007 (online)

Also available at
    Permissions and Reprints

Introduction

Once again, the past year has seen the publication of numerous new papers in the fields of gastroesophageal reflux disease (GERD) and Barrett’s esophagus. From these papers we want to focus on six relevant studies that reflect the most interesting topics in the field.

References

  • 1 Pandolfino J, Richer J, Ours T. et al . Ambulatory esophageal pH-monitoring using a wireless system.  Am J Gastroenterol. 2003;  98 740-749
    CrossrefPubMedGoogle Scholar
  • 2 Bruley des Varannes S, Mion F, Ducrotté P. et al . Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo).  Gut. 2005;  54 1682-1686
    CrossrefPubMedGoogle Scholar
  • 3 Pandolfino J, Zhang Q, Schreiner M. et al . Acid reflux event detection using the Bravo wireless versus the Slimline catheter ph systems: why are the numbers so different?.  Gut. 2005;  54 1687-1692
    CrossrefPubMedGoogle Scholar
  • 4 Wong W, Bautista J, Dekel R. et al . Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring-a randomized trial.  Aliment Pharmacol Ther. 2005;  21 155-163
    CrossrefPubMedGoogle Scholar
  • 5 Prakash C, Clouse R. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease.  Clin Gastroenterol Hepatol. 2005;  3 329-334
    CrossrefPubMedGoogle Scholar
  • 6 Vaezi M, Hicks D, Abelson T. et al . Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association.  Clin Gastroenterol Hepatol. 2003;  1 333-344
    CrossrefPubMedGoogle Scholar
  • 7 Spechler S. Laryngopharyngeal reflux: A cause of faulty phonation or a faulted phony diagnosis?.  Clin Gastroenterol Hepatol. 2006;  4 431-432
    CrossrefPubMedGoogle Scholar
  • 8 Eherer A, Habermann W, Hammer H. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study.  Scand J Gastroenterol. 2003;  38 462-467
    CrossrefPubMedGoogle Scholar
  • 9 Swoger J, Ponsky J, Hicks D. et al . Surgical fundoplication in laryngopharyngeal relux unresponsive to aggressive acid suppression: a controlled study.  Clin Gastroenterol Hepatol. 2006;  4 433-441
    PubMedGoogle Scholar
  • 10 Westcott C, Hopkins M, Bach K. et al . Fundoplication for laryngopharyngeal reflux disease.  J Am Coll Surg. 2004;  199 23-30
    PubMedGoogle Scholar
  • 11 Bittinger M. Messmann H. New endoscopic therapies for gastroesophageal reflux disease [in German].  Z Gastroenterol. 2003;  41 921-928
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Shaheen N. The rise and fall (and rise?) of endoscopic anti-reflux procedures.  Gastroenterology. 2006;  131 952-954
    CrossrefPubMedGoogle Scholar
  • 13 Rothstein R, Filipi C, Caca K. et al . Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease: A randomized sham-controlled trial.  Gastroenterology. 2006;  131 704-712
    CrossrefPubMedGoogle Scholar
  • 14 Pleskow D, Rothstein R, Lo S. et al . Endoscopic full-thickness plication for the treatment of GERD: 12-month follow-up for the North American open-label trial.  Gastrointest Endosc. 2005;  61 643-649
    CrossrefPubMedGoogle Scholar
  • 15 Lagergren J. Adenocarcinoma of the oesophagus: What exactly is the size of the problem and who is at risk?.  GUT. 2005;  54 (Suppl I) I1-I5
    CrossrefPubMedGoogle Scholar
  • 16 Murray L, Watson P, Johnston B. et al . Risk of adenocarcinoma in Barrett’s oesophagus: population based study.  BMJ. 2003;  327 534-535
    CrossrefPubMedGoogle Scholar
  • 17 Solaymani-Dodaran M, Logan R, West J, Card T. Mortality associated with Barrett’s esophagus and gastroesophageal reflux disease diagnoses - a population-based cohort study.  Am J Gastroenterol. 2005;  100 2616-2621
    CrossrefPubMedGoogle Scholar
  • 18 Anderson L, Murray L, Murphy S. et al . Mortality in Barrett’s oesophagus: Results from a population based study.  GUT. 2003;  52 1081-1084
    CrossrefPubMedGoogle Scholar
  • 19 Eckardt V, Kanzler G, Bernhard G. Life expectancy and cancer risk in patients with Barrett’s esophagus: A prospective controlled investigation.  Am J Med. 2001;  111 33-37
    CrossrefPubMedGoogle Scholar
  • 20 Sampliner R. Updates guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus.  Am J Gastroenterol. 2002;  97 1888-1895
    CrossrefPubMedGoogle Scholar
  • 21 Kara M, Bergman J. Autofluorescence imaging and narrow-band imaging for the detetction of early neoplasia in patients with Barrett’s esophagus.  Endoscopy. 2006;  38 627-631
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Kara M, Peters F, Rosmolen W. et al . High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett’s esophagus: a prospective crossover study.  Endoscopy. 2005;  37 929-936
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Kara M. Peters F, Fockens P, et al. Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett’s esophagus.  Gastrointest Endosc. 2006;  64 176-185
    CrossrefPubMedGoogle Scholar
  • 24 Weston A. Can deep freezing join the endoscopic Barrett’s mucosal ablation party? Cautious optimism is warranted.  Gastrointest Endosc. 2005;  62 849-852
    CrossrefPubMedGoogle Scholar
  • 25 Sampliner R. Endoscopic ablative therapy for Barrett’s esophagus: current status.  Gastrointest Endosc. 2004;  59 66-69
    CrossrefPubMedGoogle Scholar
  • 26 Johnston M, Eastone J, Horwat J. et al . Cryoablation of Barrett’s esophagus: a pilot study.  Gastrointest Endosc. 2005;  62 842-848
    CrossrefPubMedGoogle Scholar
  • 27 Overholt B, Lightdale C, Wang K. et al . Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial.  Gastrointest Endosc. 2005;  62 488-498
    CrossrefPubMedGoogle Scholar

H. Messmann, MD

Department of Internal Medicine III, Klinikum Augsburg

86009 Augsburg
Germany

Fax: +49-821-4003-331

Email: helmut.messmann@klinikum-augsburg.de

      >